"Genetic Engineering" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Directed modification of the gene complement of a living organism by such techniques as altering the DNA, substituting genetic material by means of a virus, transplanting whole nuclei, transplanting cell hybrids, etc.
| Descriptor ID |
D005818
|
| MeSH Number(s) |
E05.393.420
|
| Concept/Terms |
Genetic Engineering- Genetic Engineering
- Genetic Intervention
- Intervention, Genetic
- Genetic Interventions
- Interventions, Genetic
- Engineering, Genetic
|
Below are MeSH descriptors whose meaning is more general than "Genetic Engineering".
Below are MeSH descriptors whose meaning is more specific than "Genetic Engineering".
This graph shows the total number of publications written about "Genetic Engineering" by people in this website by year, and whether "Genetic Engineering" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 2 | 3 |
| 1996 | 0 | 2 | 2 |
| 1997 | 1 | 0 | 1 |
| 1998 | 0 | 3 | 3 |
| 1999 | 1 | 2 | 3 |
| 2000 | 2 | 0 | 2 |
| 2001 | 1 | 1 | 2 |
| 2002 | 1 | 2 | 3 |
| 2003 | 1 | 7 | 8 |
| 2004 | 4 | 5 | 9 |
| 2005 | 3 | 4 | 7 |
| 2006 | 1 | 5 | 6 |
| 2007 | 6 | 6 | 12 |
| 2008 | 3 | 4 | 7 |
| 2009 | 5 | 2 | 7 |
| 2010 | 1 | 6 | 7 |
| 2011 | 2 | 8 | 10 |
| 2012 | 7 | 2 | 9 |
| 2013 | 3 | 4 | 7 |
| 2014 | 1 | 4 | 5 |
| 2015 | 7 | 1 | 8 |
| 2016 | 3 | 11 | 14 |
| 2017 | 3 | 1 | 4 |
| 2018 | 5 | 7 | 12 |
| 2019 | 1 | 5 | 6 |
| 2020 | 2 | 6 | 8 |
| 2021 | 1 | 3 | 4 |
| 2022 | 1 | 4 | 5 |
| 2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Genetic Engineering" by people in Profiles.
-
An International Society for Cell & Gene Therapy working group short report on the future of expanded access to unapproved cell and gene therapies. Cytotherapy. 2023 07; 25(7):712-717.
-
Consensus statement on heart xenotransplantation in children: Toward clinical translation. J Thorac Cardiovasc Surg. 2023 09; 166(3):960-967.
-
Identifying the Metabolic Signatures of PPARD-Overexpressing Gastric Tumors. Int J Mol Sci. 2022 Jan 31; 23(3).
-
Reversing insecticide resistance with allelic-drive in Drosophila melanogaster. Nat Commun. 2022 01 12; 13(1):291.
-
Phase I clinical trial evaluating the safety and efficacy of ADP-A2M10 SPEAR T cells in patients with MAGE-A10+ advanced non-small cell lung cancer. J Immunother Cancer. 2022 01; 10(1).
-
Genome Editing Methods for Bacillus subtilis. Methods Mol Biol. 2022; 2479:159-174.
-
Determining effective drug concentrations for selection and counterselection genetics in Drosophila melanogaster. STAR Protoc. 2021 09 17; 2(3):100783.
-
DNA-encoded chemistry technology yields expedient access to SARS-CoV-2 Mpro inhibitors. Proc Natl Acad Sci U S A. 2021 09 07; 118(36).
-
The microbiome and human cancer. Science. 2021 03 26; 371(6536).
-
Applications of CRISPR Genome Editing to Advance the Next Generation of Adoptive Cell Therapies for Cancer. Cancer Discov. 2021 03; 11(3):560-574.